Livagen is a short bioregulatory tetrapeptide derived from heart tissue, studied for its potential role in cardiovascular and immune system research. Preclinical investigations explore Livagen for chromatin-activating properties and its ability to modulate gene expression in aging cardiac and immune cells. Researchers have examined its effects on immune cell restoration, anti-inflammatory signaling, and age-related cellular decline in animal models. As a member of the peptide bioregulator class, Livagen represents a growing area in geroscience. PeptideBull supplies Livagen at research-grade purity for authorized laboratory and preclinical research. Not intended for human consumption, therapeutic application, or veterinary use.
Research Articles
Livagen Peptide: A Novel Hepatoprotective Agent in Liver Research
Livagen peptide is emerging as a significant compound in liver research due to its potent hepatoprotective properties. T...
Livagen Peptide: Hepatoprotective Liver Research Insights
Discover Livagen peptide's role in hepatoprotective liver research. This article delves into its mechanisms, findings fr...